Search
for

    Sort by

    Research 481–510 of 1000+

    1. NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders Journal of Medicinal Chemistry · 2025 · 45 citations
    2. Acquired hypertrichosis lanuginosa: Case report and review of the literature Journal of surgical oncology · 1998 · 38 citations
    3. Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib Journal of the American Academy of Dermatology · 2011 · 32 citations
    4. Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment Cancers · 2021 · 29 citations
    5. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH International Journal of Oncology · 2016 · 21 citations
    6. Sorafenib-induced eruption resembling pityriasis rubra pilaris Journal of the American Academy of Dermatology · 2011 · 21 citations
    7. Upregulation of the truncated basic hair keratin 1(hHb1‐ΔN) in carcinoma cells by Epstein‐Barr virus (EBV) International Journal of Cancer · 2003 · 18 citations
    8. Cetuximab-induced hypertrichosis of the scalp and eyelashes Journal of The American Academy of Dermatology · 2010 · 12 citations
    9. Molecular Mechanisms of Vitexin: An Update on Its Anti-Cancer Functions International Journal of Molecular Sciences · 2025 · 7 citations
    10. Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers Experimental dermatology · 2022 · 7 citations
    11. Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor. PubMed · 2016 · 5 citations
    12. Role of sgk1 in cancer: a bibliometric analysis from 2013 to 2023—review article Egyptian Journal of Medical Human Genetics · 2024 · 3 citations
    13. Complex Scalp Reconstruction with Super Thin DIEP Free Flap Plastic & Reconstructive Surgery Global Open · 2024 · 1 citations
    14. SUN-911 Immunotherapy Use in Adrenocortical Carcinoma with Encouraging Results- a Case Report Journal of the Endocrine Society · 2020 · 1 citations
    15. Updates from the British Association of Dermatologists 91st Annual Meeting, 5-7 July 2011, London, U.K. British Journal of Dermatology · 2012 · 1 citations
    16. A matter of excessive hair growth Internal medicine journal · 2010 · 1 citations
    17. Are all adverse effects undesirable? a case of chemotherapy induced adverse effect- an exception!? International journal of basic and clinical pharmacology · 2021
    18. Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients Journal of Cancer Therapy · 2021
    19. Cetuximab Induced Hidrocystomas: A Case Report SKIN The Journal of Cutaneous Medicine · 2020
    20. S-1 induced discoid lupus erythematosus-like lesions and long-term complete response for para-aortic lymph node recurrence of pancreatic ductal adenocarcinoma: a case report Surgical Case Reports · 2018
    21. Posters Presented at the 19th Joint Meeting of the International Society of Dermatopathology, March 2–3, 2016, Hilton Crystal City at Washington Reagan National Airport, Arlington, Virginia, USA American Journal of Dermatopathology · 2016
    22. 696 MEK and BRAF inhibitors augment the production and accumulation of sebum in hamster sebocytes Journal of Investigative Dermatology · 2016
    23. 412 DETECTION OF CIRCULATING PROSTATE CANCER CELLS BY MEANS OF AN ANTIBODY-CONJUGATED NANOPARTICULAR BIOSENSOR European Urology Supplements · 2011
    24. Highway Deconstruction Science · 2013
    25. RANK as a therapeutic target in cancer ˜The œFEBS journal · 2016 · 50 citations
    26. The use of scalp cooling for chemotherapy-induced hair loss British journal of nursing · 2016 · 13 citations
    27. Transforming growth factor-β in stem cells and tissue homeostasis Bone Research · 2018 · 245 citations
    28. The Stem Cell Niche in Regenerative Medicine Cell stem cell · 2012 · 238 citations
    29. Matriptase: Potent Proteolysis on the Cell Surface Molecular Medicine · 2006 · 165 citations
    30. Three-Month Treatment With a Long-Acting Gonadotropin-Releasing Hormone Agonist of Patients With Benign Prostatic Hyperplasia: Effects on Tissue Androgen Concentration, 5<i>α</i>-Reductase Activity and Androgen Receptor Content* 1989 · 82 citations